{"cord_uid":"csao3flr", "sourcedb":"PMC", "sourceid":"PMC6234208", "divid":8, "text":"The avian influenza A H7N9 virus continues to be a serious threat to public health and has raised concerns of a potential pandemic. Thus, it is necessary to develop vaccines and antiviral drugs as well as neutralizing antibodies for the prevention and control of fatal H7N9 infections in humans. In the present study, we characterized a previously isolated human H7N9-neutralizing antibody (HNIgGA6) and determined the breadth of its neutralizing activity.", "project":"cdlai_CORD-19", "denotations":[]}